Human DESC1 serine protease confers tumorigenic properties to MDCK cells and it is upregulated in tumours of different origin.
about
Type II transmembrane serine protease gene variants associate with breast cancer.Targeting the membrane-anchored serine protease testisin with a novel engineered anthrax toxin prodrug to kill tumor cells and reduce tumor burden.The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment.Membrane-anchored serine proteases in health and disease.Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasisLncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
P2860
Human DESC1 serine protease confers tumorigenic properties to MDCK cells and it is upregulated in tumours of different origin.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Human DESC1 serine protease co ...... n tumours of different origin.
@en
type
label
Human DESC1 serine protease co ...... n tumours of different origin.
@en
prefLabel
Human DESC1 serine protease co ...... n tumours of different origin.
@en
P2093
P2860
P356
P1476
Human DESC1 serine protease co ...... n tumours of different origin.
@en
P2093
A Astudillo
C G Viloria
J R Peinado
M V González
O García-Suárez
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603856
P407
P577
2007-06-19T00:00:00Z
P5875
P6179
1018276930